Gnubiotics Sciences
Epalinges
About Gnubiotics Sciences
GNUBiotics is developing a compound to reproduce the natural diversity and complexity of unique structures found in breast milk. These structures are beneficial in preventing infections and the onset of diet-induced obesity. It aims at feeding the microbiome. In response to the rising demand for healthier foods they are developing functional and structural mimics of Human Milk Oligosaccharides, (HMOs) for the consumer health market. Their products reproduce the natural diversity and complexity of HMOs and have been shown to be beneficial in preventing the onset of gut infection and protect against the effect of antibiotic use.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $6.1M
- Funding stage: Early Stage Venture
- Last round: Debt Financing (Jul 2020)
- Website: gnubiotics.com
- Phone: +41 79 906 92 27
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/gnubiotics-sciences-50620 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.